ArticleChemistry & biodiversity2026
Quinolinone and Amicoumacin Derivatives From the Deep Sea-Derived Bacillus rugosus SCSIO 41395 and Their Bacteriostatic Activities Against Pseudomonas aeruginosa.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Two new natural 2-alkylquinolin-4(1H)-one derivatives, 2-(5-methylheptyl) quinolin-4(1H)-one (1) and 2-(5-methylnonane) quinolin-4(1H)-one (2), along with ten known compounds (3-12), were isolated from the strain of Bacillus rugosus SCSIO 41395, which was obtained from the sediments of the Philippine Basin. All the isolates were evaluated for bacteriostatic activities against Pseudomonas aeruginosa (PA). Compounds 4 and 5 exhibited bacteriostatic effects by inhibiting the expression of rhl, pqs, and las quorum-sensing genes, as well as suppressing related phenotypes, including rhamnolipid, pyocyanin production, and biofilm formation. Our findings suggest that compounds 4 and 5 are promising quorum-sensing inhibitors for potential alternative treatments of PA infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.